NeurotechMagProGet access
Research Paper

Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain-a multicenter pragmatic randomized controlled trial (RESET)

Pain Medicine1/4/2026ยท01/04/26๐ŸŒ USA

Summary

The RESET trial randomized 230 patients with chronic low back pain to percutaneous 60-day PNS versus usual care. At 3 months, 55% of PNS patients achieved at least 50% pain relief compared to 26% in the usual care group, with sustained benefits through 6 months.

Why it matters

This pragmatic RCT provides high-quality evidence for temporary percutaneous PNS as an effective intermediate option before permanent implantation. The 60-day duration offers a reversible trial period that could improve patient selection for long-term neuromodulation.

#Chronic Pain#Neurostimulation#Non-invasive#Neural Interfaces

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in